The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity
Open accessAbstract
Cancer is considered one of the primary diseases that cause morbidity and mortality in millions of people worldwide and due to its prevalence, there is undoubtedly an unmet need to discover novel anticancer drugs. However, the traditional process of drug discovery and development is lengthy and expensive, so the application of in silico techniques and optimization algorithms in drug discovery projects can provide a solution, saving time and costs. A set of 617 approved anticancer drugs, constituting the active domain, and a set of 2,892 natural products, constituting the inactive domain, were employed to build predictive models and to index natural products for their anticancer bioactivity. Using the iterative stochastic elimination optimization technique, we obtained a highly discriminative and robust model, with an area under the curve of 0.95. Twelve natural products that scored highly as potential anticancer drug candidates are disclosed. Searching the scientific literature revealed that few of those molecules (Neoechinulin, Colchicine, and Piperolactam) have already been experimentally screened for their anticancer activity and found active. The other phytochemicals await evaluation for their anticancerous activity in wet lab.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Levine, A. J., & Puzio-Kuter, A. M. (2010) · Science · doi:10.1126/science.1193494 · Cited by 1,243
Tumor suppressors and cell metabolism: a recipe for cancer growth
Jones, R. G., & Thompson, C. B. (2009) · Genes & Development · doi:10.1101/gad.1756509 · Cited by 1,085
Lusci, A., Pollastri, G., & Baldi, P. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400187y · Cited by 555
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Opportunities for natural products in 21st century antibiotic discovery
Wright, G. D. (2017) · Natural Product Reports · doi:10.1039/c7np00019g · Cited by 343
The structural modification of natural products for novel drug discovery
Yao, H., Liu, J., Xu, S., Zhu, Z., & Xu, J. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1272757 · Cited by 275
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer
Joshi, P., Vishwakarma, R. A., & Bharate, S. B. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.047 · Cited by 174
Shen, M., Béguin, C., Golbraikh, A., Stables, J. P., Kohn, H., & Tropsha, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030584q · Cited by 150
Potential anticancer role of colchicine-based derivatives: an overview
Kumar, A., Sharma, P. R., & Mondhe, D. M. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000464 · Cited by 132
Introduction to the molecular basis of cancer metabolism and the Warburg effect
Ngo, D. C., Ververis, K., Tortorella, S. M., & Karagiannis, T. C. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3857-y · Cited by 90
Aswad, M., Rayan, M., Abu‐Lafi, S., Falah, M., Raiyn, J., Abdallah, Z., & Rayan, A. (2017) · Inflammation Research · doi:10.1007/s00011-017-1096-5 · Cited by 89
Self-citationCern, A., Marcus, D., Tropsha, A., Barenholz, Y., & Goldblum, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.015 · Cited by 71
Catalase inhibition an anti cancer property of flavonoids: A kinetic and structural evaluation
Majumder, D., Das, A., & Saha, C. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.06.100 · Cited by 55
Kačergius, T., Abu‐Lafi, S., Kirkliauskienė, A., Gabė, V., Adawi, A., Rayan, M., Qutob, M., Stukas, R., Utkus, A., Zeidan, M., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6674 · Cited by 47
Self-citationGlick, M., Rayan, A., & Goldblum, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022418199 · Cited by 44
Self-citationUddin, R., Yuan, H., Petukhov, P. A., Choudhary, M. I., & Madura, J. D. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci8000056 · Cited by 41
Methanol extract of the ethnopharmaceutical remedy Smilax spinosa exhibits anti-neoplastic activity
Seelinger, M., Popescu, R., Giessrigl, B., Jarukamjorn, K., Unger, C., Wallnöfer, B., Fritzer‐Szekeres, M., Szekeres, T., Díaz, R. E., Jäger, W. R., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1538 · Cited by 39
Heikamp, K., & Bajorath, J. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci4002712 · Cited by 36
Exploring the conformational space of cyclic peptides by a stochastic search method.
Rayan, A., Senderowitz, H., & Goldblum, A. (2004) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2003.12.012 · Cited by 33
Self-citationPredicting Oral Druglikeness by Iterative Stochastic Elimination
Rayan, A., Marcus, D., & Goldblum, A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9004354 · Cited by 29
Self-citationComputational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads
Zatsepin, M., Mattes, A., Rupp, S., Finkelmeier, D., Basu, A., Burger‐Kentischer, A., & Goldblum, A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00070 · Cited by 29
Frank, A., Abu‐Lafi, S., Adawi, A., Schwed, J. S., Stark, H., & Rayan, A. (2017) · Inflammation Research · doi:10.1007/s00011-017-1075-x · Cited by 23
Self-citationZeidan, M., Rayan, M., Zeidan, N. Y., Falah, M., & Rayan, A. (2017) · Molecules · doi:10.3390/molecules22091563 · Cited by 22
Self-citationIndexing molecules for their hERG liability
Rayan, A., Falah, M., Raiyn, J., Da'adoosh, B., Kadan, S., Zaid, H., & Goldblum, A. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.059 · Cited by 21
Self-citationClassifying Large Chemical Data Sets: Using A Regularized Potential Function Method
Mussa, H. Y., Hawizy, L., Nigsch, F., & Glen, R. C. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100022u · Cited by 13
How to Choose the Suitable Template for Homology Modelling of GPCRs: 5‐HT7 Receptor as a Test Case
Shahaf, N., Pappalardo, M., Basile, L., Guccione, S., & Rayan, A. (2016) · Molecular Informatics · doi:10.1002/minf.201501029 · Cited by 13
Self-citation
Cited by
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine
Lin, Y., Zhang, Y., Wang, D., Yang, B., & Shen, Y.-Q. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154481 · Cited by 107
Role of Mangiferin in Management of Cancers through Modulation of Signal Transduction Pathways
Rahmani, A. H., Almatroudi, A., Allemailem, K. S., Alharbi, H. O. A., Alwanian, W. M., Alhunayhani, B. A., Algahtani, M., Theyab, A., Almansour, N. M., Algefary, A. N., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11123205 · Cited by 22
Metadata
- Authors
- Rayan, A., Raiyn, J., & Falah, M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-11-09
- Volume
- 12
- Issue
- 11
- Pages
- e0187925
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2767416953
- Cited by
- 351
- References
- 31
- FWCI
- 18.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.